It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...

The supply shortage and high costs of GLP-1 weight loss drugs have created an opportunity for compounded GLP-1 treatments to ...

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

Advocates say microdosing reduces costs and side effects while maintaining weight loss, then can help with weight maintenance ...

SLW: The part of dairy that is very well-positioned to assist consumers on their GLP-1 journey is yogurt. The functional benefits including protein, pre- and probiotics, variety of low and no sugar ...

Related Cosmetic surgeons try to correct 'Ozempic face' for weight-loss drug users Massive study looks at benefits, risks of GLP-1 weight-loss drugs FDA says shortage of GLP-1 drug tirzepatide is ...

We know now that glucagon-like peptide 1 (GLP-1) drugs for obesity bring with them ... patients experienced a laundry list of positive health outcomes, including a reduced risk for: Substance ...

The company has been a big beneficiary of GLP-1 drugs that have seen soaring demand as they have been shown to greatly help with multiple health issues, including weight control. The stock has ...

The GLP-1 compound drug sold by Hims and Hers is not approved by the FDA and its Super Bowl ad fails to list any risks ...

Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The situation is causing the FDA regulatory headaches and, more seriously, posing ...

Novo Nordisk's CEO is not worried about blockbuster semaglutide drugs being added to Medicare drug pricing negotiations this ...